Two versions of the AstraZeneca/Oxford COVID-19 vaccine authorised by WHO for emergency use

The World Health Organisation (WHO) has authorised two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use. A statement from the WHO said that the vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.  

WHO’s Emergency Use Listing (EUL) assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.  

“Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk, contributing to the COVAX Facility’s goal of equitable vaccine distribution,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products.  

‘But we must keep up the pressure to meet the needs of priority populations everywhere and facilitate global access. To do that, we need two things – a scale-up of manufacturing capacity, and developers’ early submission of their vaccines for WHO review.”  

Photo Credit : https://commons.wikimedia.org/wiki/File:AstraZeneca_COVID-19_Vaccine_(cropped).jpg